Literature DB >> 6893216

The phagocytosis stimulating peptide tuftsin: further look into structure-function relationships.

Y Stabinsky, P Gottlieb, M Fridkin.   

Abstract

Sixteen new analogs of the phagocytosis-stimulating peptide tuftsin have been synthesized. The biological activities of these synthetic peptides, in which either the C-terminal or both C- and N-terminals are chemically altered, were evaluated by studying their effects on the phagocytosis of heat-killed yeasts and on the reduction of the dye nitroblue tetrazolium by normal human polymorphonuclear leukocytes. The results demonstrate that the integrity of the guanidine side chain of arginine at position four of tuftsin is crucial for maximal activity. Modification, even in side chain length, of the guanidine leads to decreasing activity. Preservation of the positive charge of position four of tuftsin yields analogs possessing considerable activity. Simultaneous alterations of both C- and N-terminal results in diminishing activities. The results of this study are discussed in relation to the structural features of tuftsin. It appears that interaction between the carboxyl of Arg4 and the amino group of Thr1 which would indicate a specific conformation such as a 4 leads to 1 beta-turn are not favored.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6893216     DOI: 10.1007/bf00230170

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  20 in total

1.  Tuftsin (an Ig-associated tetrapeptide) triggers the immunogenic function of macrophages: implications for activation of programmed cells.

Authors:  E Tzehoval; S Segal; Y Stabinsky; M Fridkin; Z Spirer; M Feldman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

Review 2.  Phagocytosis (third of three parts).

Authors:  T P Stossel
Journal:  N Engl J Med       Date:  1974-04-11       Impact factor: 91.245

3.  The characteristics, isolation and synthesis of the phagocytosis stimulating peptide tuftsin.

Authors:  K Nishioka; A Constantopoulos; P S Satoh; V A Najjar
Journal:  Biochem Biophys Res Commun       Date:  1972-04-14       Impact factor: 3.575

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Effect of tuftsin on migration of polymorphonuclear and mononuclear human leukocytes in leukocyte migration agarose test.

Authors:  A Horsmanheimo; M Horsmanheimo; H H Fudenberg
Journal:  Clin Immunol Immunopathol       Date:  1978-11

6.  Migration enhancement by tuftsin of human mononuclear cells and its effect on the migration inhibition factor test with tumor antigens.

Authors:  K Nishioka
Journal:  Gan       Date:  1978-08

7.  [Synthesis of peptides related to tuftsin. II (author's transl)].

Authors:  K Yasumura; K Okamoto; S Shimamura
Journal:  Yakugaku Zasshi       Date:  1977-03       Impact factor: 0.302

8.  The effect of Tuftsin on the nitrous blue tetrazolium reduction of normal human polymorphonuclear leukocytes.

Authors:  Z Spirer; V Zakuth; A Golander; N Bogair; M Fridkin
Journal:  J Clin Invest       Date:  1975-01       Impact factor: 14.808

9.  Tuftsin-macrophage interaction: specific binding and augmentation of phagocytosis.

Authors:  Z Bar-Shavit; Y Stabinsky; M Fridkin; R Goldman
Journal:  J Cell Physiol       Date:  1979-07       Impact factor: 6.384

10.  Nuclear magnetic resonance studies on the structure of the tetrapeptide tuftsin, L-threonyl-L-lysyl-L-prolyl-L-arginine, and its pentapeptide analogue L-threonyl-L-lysyl-L-prolyl-L-prolyl-L-arginine.

Authors:  M Blumenstein; P P Layne; V A Najjar
Journal:  Biochemistry       Date:  1979-11-13       Impact factor: 3.162

View more
  1 in total

Review 1.  Tuftsin, Thr-Lys-Pro-Arg. Anatomy of an immunologically active peptide.

Authors:  M Fridkin; P Gottlieb
Journal:  Mol Cell Biochem       Date:  1981-12-04       Impact factor: 3.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.